Free Wanderer Powder regulates AMPA receptor homeostasis in chronic restraint stress-induced rat model of depression with liver-depression and spleen-deficiency syndrome.

AMPA receptor chronic restraint stress depression free wanderer powder homeostasis

Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
14 Oct 2020
Historique:
received: 26 09 2019
accepted: 23 02 2020
pubmed: 15 10 2020
medline: 15 10 2020
entrez: 14 10 2020
Statut: ppublish

Résumé

Free Wanderer Powder (FWP) is a classic formula for depression with digestive dysfunctions, i.e., liver-depression and spleen-deficiency syndrome (LDSDS) in Chinese Medicine. But its protective mechanism has not been fully clarified. Here a chronic restraint stress (CRS) induced rat model showed depression with LDSDS in food intake, metabolism, and behaviour tests. Then 75 rats were randomly divided, and received CRS and different treatment with behaviour tests. Expressions of c-Fos and AMPA-type glutamate receptor subunits GluR1-3 in hippocampus CA1, CA3, DG and amygdala BLA were detected by immunohistochemistry, western blot and RT-PCR, respectively. In CRS rats, FWP alleviated depressive behaviour and c-Fos expression. FWP suppressed the increasement of GluR1 in CA1 and DG, p-GluR1 in CA1, and p-GluR2 and GluR3 in BLA. FWP also blocked the decrease of GluR1 and Glur2/3 in CA3, p-GluR1 in CA3, and p-GluR2 in CA1 and CA3. Furthermore, constituents of FWP and their potential targets were explored using UHPLC-MS and systematic bioinformatics analysis. There were 23 constituents identified in FWP, 9 of which regulated glutamatergic synapse. Together, these results suggest that FWP contains effective constituents and alleviates depression with LDSDS by regulating AMPA-type glutamate receptor homeostasis in amygdala and hippocampus.

Identifiants

pubmed: 33052137
doi: 10.18632/aging.103912
pii: 103912
pmc: PMC7732332
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19563-19584

Auteurs

Shengyan Xi (S)

Department of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen 361102, China.

Guangxin Yue (G)

China Academy of Chinese Medical Sciences, Beijing 100700, China.

Yueyun Liu (Y)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

Yanan Wang (Y)

Department of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen 361102, China.

Yingkun Qiu (Y)

School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.

Zhigeng Li (Z)

China Academy of Chinese Medical Sciences, Beijing 100700, China.

Pei Ma (P)

Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.

Tiegang Liu (T)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

Youming Jiang (Y)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

Yuan Liang (Y)

China Academy of Chinese Medical Sciences, Beijing 100700, China.

Qun Liu (Q)

China Academy of Chinese Medical Sciences, Beijing 100700, China.

Jing Shi (J)

The 3rd Neurology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.

Jiaxu Chen (J)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

Lifeng Yue (L)

The 3rd Neurology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.

Classifications MeSH